Tag: RNN

Blue Horseshoe Stocks: LPCN Recap, LPDX & More

Lipocine, Inc. LPCN

LPCN served up an opportunity at some decent intraday gains after appearing on yesterday morning’s extended watchlist.

The stock played out a classic dip and rip scenario, falling to a morning low of 6.89 before surging back in the afternoon to a subsequent high of 8.42. That offered traders a chance at intraday gains of up to 22% on plenty of liquidity- the stock would trade 23.5X its 30-day average volume.

The productive session came on the heels of the company announcing favorable results from Phase-3 clinical testing of “LPCN 1021”, its oral treatment for low testosterone >>> VIEW PR

LipoScience, Inc. LPDX

LPDX is gapping up heavily in the premarket, and the interesting story behind it is one that we’re definitely going to want to give our close attention. Early this morning, the company announced that it was the subject of a buyout that would be executed at a share price of $5.25. Barely an hour later, another PR hit the LPDX newswire, concerning an investigation of the managerial board’s handling of the deal, and whether or not they have secured the best possible buyout price.

According to the investigative firm leading the case, “The $5.25 per share acquisition price is far less than where the stock has recently traded. In fact, on January 25, 2013, LipoScience stock opened for trading at $9.75 the day the Company sold 5.0 million shares of stock in its initial public stock offering.” >>> VIEW PR

The playing out of this scenario is going to be an interesting story moving forward, which is why we wanted to flag LPDX this morning, and fill everyone in on this morning’s happenings. The possibility that the investigation could lead to a potential restructuring of the buyout is enough to have us keep our ears to the tracks on this one for the foreseeable future.

Magnum Hunter Resources Corp. MHR

MHR is another morning gapper that we’re putting on our radars. This morning Magnum announced impressive throughput volumes on its “Eureka Hunter” gas gathering pipeline. According to the CEO, “increased capacity has resulted in a record day of approximately 316,500 MMBtu of natural gas”. >>> VIEW PR

Options Trading Idea: PBR Calls 

We’re interested in the PBR October 31st $15.50 Calls  last traded at 1.88. If we can see PBR make its way back to recent $20+ highs within a month, it could put us in position to see returns of up to 150-200% on those contracts.

Extended Watchlist:
 RNN, MNKD, CNET, VHC, MPET

Blue Horseshoe Stocks: Bottom Plays, Pot Stocks & More

Legacy Platinum Group, Inc. LWSP
–
The latest addition to our cannabis watchlist, we introduced LWSP in yesterday’s daily report. After consolidating off of a recent 39-cent high, the stock has made higher highs and higher lows off of its bottom.

Yesterday the stock traded from its low of .187, and ran 12% into the close, ending the session at its high-of-day, .21. We always like to see a stock finish on a high note, as it is often a precursor to further gains.

BARCHART.COM is currently giving LWSP a 96% Overall “Buy” Rating 

MannKind Corp. MNKD

MNKD serves as the latest example of why we highly suggest all of our readers keep a running list of the stocks we place in our daily Extended Watchlists.

We included this play in Friday’s report as it had been in near free-fall and the possibility of a bounceplay was present. The stock ended up finding support at 4.02, and yesterday after-hours we spied a PR regarding recommendation from an FDA Advisory panel to green-light the company’s AFREZZA(R) insulin inhalation powder.

As a result, the stock is gapping up significantly in pre-market action today, so we’ll want to keep a close watch over this potential breakout play.

VALENCIA, Calif., April 1, 2014 (GLOBE NEWSWIRE) — MannKind Corporation (MNKD) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 13 to 1 to recommend that AFREZZA(R) (insulin human [rDNA origin]) Inhalation Powder be granted marketing approval by the FDA to improve glycemic control in adults with type 1 diabetes and voted 14 to 0 to recommend that AFREZZA be granted marketing approval by the FDA to improve glycemic control in adults with type 2 diabetes. If approved, AFREZZA would be the first ultra rapid-acting mealtime insulin therapy available in the United States. >> FULL PR

Alternative Fuels Americas, Inc. AFAI

Speaking of potential bottom plays with fresh news on the wires, we caught AFAI in our morning scan today, and as it turns out, this is another marijuana-related stock. That fact alone is enough to grab our attention.

We have yet to see much news in this sector from Florida, one of the latest states with a medical marijuana initiative on its ballot, so we’ll be interested to follow this storyline as well.

HOLLYWOOD, Fla., April 2, 2014 /PRNewswire/ — Alternative Fuels Americas, Inc. (AFAI) announced today that its subsidiary Marijuana Holdings Americas, Inc. has founded and will sponsor the Florida Cannabis Industry Association (FLCIA), the primary trade association for Florida’s emerging cannabis industry. >> FULL PR

Prana Biotechnology, Inc. PRAN

In Monday’s Extended Watchlist, we called PRAN a “Huge gap down, possible bounce-play”. The downward pressure continued through yesterday’s session, and the stock closed at 2.30, just .03 off of its low.

This morning, we are seeing the beginning signs of a potential recovery; PRAN is gapping up to the tune of 4% in pre-market trading. We’ll continue to keep this stock on watch, in the event it can regain some of its recent lost ground. Trading over $10 as recently as March 26th, a return to even a fraction of those levels would mean significant opportunity for the sharp trader.

Extended Watchlist:
ENVI, RNN, KIOR, SOL, CPST, DLLR(Possible Buyout)

Blue Horseshoe Stocks: FRTD, A Word on the Cannabis Sector

Fortitude Group, Inc. FRTD

We sincerely hope that our readers caught yesterday morning’s report, and read all the way through to the Extended Watchlist where we included FRTD as new cannabis momentum play. The head of steam that the stock began to build on the heels of a recent series of PR’s regarding the company’s entry into the trendy cannabis sector led to continued advances during yesterday’s session.

We saw FRTD touch a low of .0081 before exploding to its high-of-day at .018, a positive intraday move of 122%

FRTD is just the latest in the long line of companies we’ve seen take advantage of the hysterical nature of 2014’s “Green Rush”. While much of the initial fervor we witnessed in December and January has relaxed, don’t expect to stop hearing about this sector anytime soon. In fact, as more and more data comes in, we expect the marijuana business to grow exponentially as each state realizes the financial benefits and caves to economic pressure.

This hypothesis was reinforced by the January tax numbers from Pueblo Country, CO (where the substance is now completely legal) came in. See THIS ARTICLE, which shows that based on their January tax income from marijuana sales, the county stands to increase their annual bugdet by nearly 5%  Colorado is currently serving as an experimental template, and you can be sure that all across the nation, legislators and business people alike are watching intently.

In other news, US banks are quickly clearing hurdles in the way of providing services to pot-related business, and the general sentiment in Washington, is to let this all play out naturally. Even the current administration has made statements which set the table for widespread marijuana reform. Several legislators have petitioned the president to reclassify marijuana, a relatively harmless substance when considering the fact that it now shares a classification with heroin and similarly dangerous drugs.

While many obstacles remain to be navigated, the proverbial ball has begun rolling, and it seems now that there is little that can ultimately stand in the way of progress.


MOST RECENT PR:

ERIE, PA, Feb 24, 2014 (Marketwired via COMTEX) — Fortitude Group, Inc. (OTC: FRTD) CEO Thomas J. Parilla is pleased to announce that on February 22, 2014, the Company executed a Master Agent Agreement with eViteXchange.com. Under the terms of the agreement, Fortitude will offer and facilitate closed-loop transaction processing to legal dispensaries in the medical marijuana industry as well as provide processing for entities in states that have legalized recreational marijuana sales.

Fortitude shall acquire from eViteXhange.com the URL’s 420banc.com and 420cashcard.com. Both domains will be used as a pre-paid platform allowing legal marijuana merchants customers to process purchase transactions using a debit card vs. cash. The private-label card will offer additional rewards and points to the card holders which can be custom designed to fit their individual likes and needs. Fortitude expects to derive approximately $155.00 annual profit per retail card user. The Company intends to launch on March 17, 2014.

Be sure to stay tuned to our reports, and/or check our blog at BlueHorseshoeStocks.com regularly. We’re continuously tracking the cannabis sector as a whole, and often add new plays just like FRTD to the list.

Extended Watchlist:
PLUG, LJPC, DGAZ, FNMA, FMCC, RNN, JCP, IMRS

ERBB, AEGY, BDSI & Extended Watchlist

Tranzbyte Corp. ERBB
–
We highlighted ERBB on Friday and the stock came out swinging, continuing the momentum that was building in the previous session.It came out of the gate strong, running quickly from a low of .0119 up as high as .0154. That marks a respectable intraday move of 29%As the stock pulls back off of that run, we’d like to see support hold over a penny, and will be monitoring the situation for any possible bounce opportunities.

Alternative Energy Partners, Inc. AEGY

We’ve had AEGY on our radar since last spring, and after a serious increase in recent trading activity, we wanted to bring it back into the conversation. The stock has been in full-on breakout mode for the past couple of sessions, and appears to want to gap up even further this morning.  What we are going to want to do is watch carefully for any possible dip-and-rip opportunities. Stocks that gain so much ground over so short a time-frame are susceptible to high volatility and sudden pullbacks, and are often followed by what can be very lucrative bounceplays for quick-witted traders.

This is another of the medical marijuana related stocks that we’ve been tracking for a long while. AEGY, in particular, operates pharmajanes.com an online dispensary for California residents, but the list of companies that we’ve tracked cover every part of the sector, from medical to legal cannabis, to growing apparatus, and more.

To list a few of the standouts we’ve tracked over an extended time: EAPH, FITX, CBIS, HEMP, PHOT, MJNA, SKTO, TRTC, EDXC, MWIPD, EXMT, CANN, MDBX, GWPH and that’s only a partial list. Cannabis has been allowing a lot of people to cash in via the stock market, and we expect the opportunities to keep coming.

BioDelivery Sciences International, Inc. BDSI
–
BDSI appeared in Friday’s Extended Watchlist and made a notable 16% intraday move, trading from a low of 8.18 to 9.49 on almost 15M shares traded. The spike in price and volume comes on the heels of Thursday’s PR regarding positive testing results for the pain medication the company has under development:
–

Extended Watchlist:
REVI, RITT, NWBO, MM, ALU, CLSN, HIHO, RNN

Blue Horseshoe Stocks: Cannabis Update & More

Pot Stocks Update
–
On Friday, we surmised that the general consolidation after last week’s epic surge in the cannabis sector would lead to rebounds for many of the pot stocks that we’ve been tracking long-term, and were correct in our assumption. Not an especially impressive feat, considering the fact that we’ve seen the bottom-bounce scenario play out hundreds of times; it’s practically a law of nature.

The following are some of the more notable cannabis bounce-plays that we observed to start the week:
–
Transbyte Corp. ERBB

ERBB reached a bottom (.0057) Friday shortly after 10am, and has done a fine job of bouncing back. Yesterday we saw the stock trade as high as .0098, closing just one tick below at .0097 on more than thrice the 3-month average volume. That’s a 72% swing spanning consecutive sessions.

Hemp, Inc. HEMP

HEMP came down from its big run over eight cents to find support at .031, from which point it has found its way back up to .06. That rebound was good for gains as high as 94% Like ERBB, HEMP finished out Monday’s session near its high-of-day, closing at .0594.

Creative Edge Nutrition, Inc. FITX

FITX is one that has done exceptionally well with regard to holding most of its recent gains when it did pull back. If you recall, we witnessed a low of .0056 last Monday, and the consolidation off of its highs at .031 only took it as low as .0111. The stock has recovered nicely, pushing its way back to .0265 during yesterday’s session; a bounce-play worth gains of up to 139%

GreenGro Technologies, Inc. GRNH

Unsurprisingly, one of the biggest runners from the ‘Green Rush’ turned out one of the bigger bounces on its recovery. It came down from its highs well over a dollar, and bounced off of the .20-mark yesterday, only to rebound as high as .49, a 145% swing. This morning in pre-market trading it has poked its head back over fifty cents.

Growlife, Inc. PHOT

PHOT touched bottom at .18 on Friday, and as of yesterday had pushed its way back to a high of .293. That represents a 62% bounce. PHOT is holding its ground in early trading this morning.

SK3 Group, Inc. SKTO

SKTO dipped back to .0115 Friday, and followed the trend of recovery yesterday, achieving a price of .0235, marking a two-session swing of 104%

Other cannabis stocks that were on the rebound Monday included TRTC, AVTC & CANN

Rexhan Pharmaceuticals, Inc. RNN

It became apparent that RNN would continue its recent uptrend early-on yesterday. Even though we had already seen impressive gains amounting to nearly 200% in a range from .4026-1.19 up to that point, it continued to surge, reaching its peak at 1.85.

RNN is trading in the 1.40’s pre-market, so like the other massive gainers we’ve followed over the past week, we’ll be continuously monitoring for support and the potential for a subsequent bounce.

Get Our FREE Daily Reports!

SUBSCRIBE